Menu
Not yet recruiting NCT07531030

Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks for Hip Surgery Analgesia

No phase Interventional Postoperative Pain Hip Osteoarthritis Hip Fractures

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Posterior Pericapsular Deep Gluteal, Pericapsular Nerve Group, and Lateral Femoral Cutaneous Nerve Blocks., Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks..
Who it may be relevant to
Registry conditions: Postoperative Pain, Hip Osteoarthritis, Hip Fractures. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Efficacy of Combining Ultrasound-guided Posterior Pericapsular Deep Gluteal Block to Both Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks for Postoperative Analgesia in Orthopedic Hip Surgeries

Overview

This study aims to investigate the efficacy of adding a Posterior Pericapsular Deep gluteal block to two other standard nerve blocks-the Pericapsular Nerve Group block and the Lateral Femoral Cutaneous Nerve block-for patients undergoing orthopedic hip surgery. While standard blocks target the front of the hip, many patients still feel pain in the back (posterior) of the joint. Researchers will compare two groups of patients to see if this triple-block combination provides better pain relief and reduces the need for rescue opioid medications in the 24 hours following surgery.

Detailed description

Patients undergoing elective orthopedic hip surgery will be randomly assigned to one of two groups. Both groups will receive general anesthesia followed by ultrasound-guided nerve blocks. Group 1 will receive a Pericapsular Nerve Group block and a Lateral Femoral Cutaneous Nerve block using 0.25% bupivacaine. Group 2 will receive these same two blocks plus an additional Posterior Pericapsular Deep gluteal block, also using 0.25% bupivacaine.

The primary goal is to evaluate postoperative pain using the Numerical Rating Scale at 6, 12, and 24 hours for both static and dynamic states. Secondary objectives include assessing quadriceps muscle strength using the Lovett Grading Method, measuring total rescue analgesia (nalbuphine) consumption, and monitoring for any complications or differences in length of hospital stay.

Interventions

  • Procedure Posterior Pericapsular Deep Gluteal, Pericapsular Nerve Group, and Lateral Femoral Cutaneous Nerve Blocks.
    Under ultrasound guidance, patients receive a Pericapsular Nerve Group block, a Lateral Femoral Cutaneous Nerve block, and a Posterior Pericapsular Deep gluteal block. For each of the three blocks, 10-15 ml of 0.25% bupivacaine is injected while observing for adequate fluid spread over the respective anatomical targets.
  • Procedure Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks.
    Patients receive ultrasound-guided Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve blocks with 10-15 ml of 0.25% bupivacaine for each block.

Primary outcome measures

  • Evaluation of Postoperative analgesic effect through Numerical Rating Scale Pain Score. [Time frame: 6, 12, and 24 hours postoperatively.]
Secondary outcome measures (4)
  • Quadriceps Femoris Muscle Strength. [Time frame: 1 hour before patient movement.]
  • Total Rescue Analgesia Consumption. [Time frame: First 24 hours postoperatively.]
  • Length of Hospital Stay. [Time frame: Approximately 24-72 hours (up to hospital discharge).]
  • Occurrence of Postoperative Complications. [Time frame: First 24 hours postoperatively.]

Eligibility criteria

Inclusion criteria

  • Age greater than or equal to 18 years.
  • Both genders included.
  • American Society of Anesthesiologists (ASA) physical status classification I-III.
  • Undergoing elective orthopedic hip surgery.
  • Provision of written informed consent.

Exclusion criteria

  • Patient refusal of procedure or participation.
  • American Society of Anesthesiologists (ASA) physical status classification IV.
  • Allergy to any of the drugs used in the study.
  • Local skin infection at the injection site.
  • Coagulation disorder.
  • History of cardiac arrhythmia, seizures, or increased intracranial tension.
  • Alcohol or drug abuse, or psychiatric disease.
  • History of chronic pain.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Egypt · 1 center
  • Ain Shams University — Cairo

Identifiers

NCT: NCT07531030 · FMASU MD274/2025

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗